Average Co-Inventor Count = 2.56
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (18 from 136 patents)
2. Zystor Therapeutics, Inc. (5 from 5 patents)
23 patents:
1. 11351231 - Lysosomal targeting peptides and uses thereof
2. 11254725 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
3. 10301369 - Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
4. 10300113 - Targeted therapeutic proteins
5. 9845346 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
6. 9834587 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
7. 9834588 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
8. 9814762 - Targeted therapeutic proteins
9. 9771408 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
10. 9469683 - Lysosomal targeting peptides and uses thereof
11. 9376480 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
12. 8859498 - Targeted therapeutic proteins
13. 8785168 - Formulations for lysosomal enzymes
14. 8563691 - Lysosomal targeting peptides and uses thereof
15. 8492337 - Targeted therapeutic proteins